Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: testing (1000), conducting tests (149)

CRF_Letterhead_v6_NIHR

Description: Southampton Clinical Research Facility University Hospital Southampton NHS Foundation Trust C Level West Wing, Mailpoint 218 Southampton SO16 6YD Tel: 02
Url: /Media/Southampton-Clinical-Research/CRF-templates/CRF-Letterhead-v6-NIHR.docx

CRF_Letterhead_v5_NIHR

Description: Southampton Clinical Research Facility University Hospital Southampton NHS Foundation Trust C Level West Wing, Mailpoint 218 Southampton SO16 6YD Tel: 02
Url: /Media/Southampton-Clinical-Research/CRF-templates/CRF-Letterhead-v5-NIHR.docx

Enrico Tambellini, clinical research facility manager

Description: NIHR Southampton Clinical Research Facility Auto Generated Title Enrico ensures the availability and quality of the facilities and equipment needed to
Url: /ClinicalResearchinSouthampton/Our-people/Clinical-research-facility-people/Enrico-Tambellini-clinical-research-facility-manager.aspx

PPI Terms of reference

Description: Terms of referenceThis document contains the terms of reference (TOR) for the Patient and Public Involvement (PPI) Group for Southampton Centre
Url: /Media/Southampton-Clinical-Research/PPI/PPI-Terms-of-reference.pdf

Anti-CGRP monoclonal antibodies (mAbs) for the prevention of episodic and chronic migraine - patient information

Description: This factsheet contains information about a preventative treatment for episodic and chronic migraine called anti-CGRP monoclonal antibodies (mAbs).
Url: /Media/UHS-website-2019/Patientinformation/Brain-and-spine/Anti-CGRP-monoclonal-antibodies-mAbs-for-the-prevention-of-episodic-and-chronic-migraine-3075-PIL.pdf

Sponsor-Request-Form_Jan2020

Description: UHS Sponsorship Application Section 1 – To be completed for all projects requesting UHS to act as Sponsor Study title 1. Propose
Url: /Media/Southampton-Clinical-Research/Downloads/Sponsor-Request-Form-Jan2020.docx

Papers Trust Board 6 June 2024

Description: Date Time Location Chair Apologies Agenda Trust Board – Open Session 06/06/2024 9:00 - 13:00 Conference Room, Heartbeat/Microsoft
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2024-Trust-documents/Papers-Trust-Board-6-June-2024.pdf

MPF12 HaemOnc request form v10

Description: UHS LAB USE Specimen(s) received (central): BMT / Slides / BMA EDTA / PB EDTA / Cyto / other Specimen(s) distribution: Histo MGG Flow
Url: /Media/UHS-website-2019/Docs/Health-professionals/Pathology/MPF12-HaemOnc-request-form.docx

Papers Trust Board - 30 January 2024

Description: Date Time Location Chair Apologies Agenda Trust Board – Open Session 30/01/2024 9:00 - 13:00 Conference Room, Heartbeat/Microsoft
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2024-Trust-documents/Papers-Trust-Board-30-January-2024.pdf

Sunitinib v1

Description: Chemotherapy Protocol SARCOMA Gastro-Intestinal Stromal Tumour (GIST) Regimen Sunitinib GIST-Sunitinib Indication Sunitinib is recommended as a possible treatment for
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/Sunitinib-v1.pdf

181 to 190 of 517

Previous … 17 18 19 20 21 … Next